OCTAPHARMA AG

In News

Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG - PR Newswire

PR Newswire - Feb 25, 2026

ALN, Octapharma Plasma Agree to Settle Breach Lawsuits - BankInfoSecurity

BankInfoSecurity - Oct 10, 2025

'Network issues' close Octapharma Plasma centers in Columbus and U.S. - The Columbus Dispatch

The Columbus Dispatch - Apr 19, 2024

Octapharma AG, CSL Behring LLC, and Grifols S.A. Lead the Global Plasma Protein Therapeutics Market - GlobeNewswire

GlobeNewswire - Jul 21, 2023

Octapharma Plasma expanding U.S. HQ with $18.75M building acquisition - The Business Journals

The Business Journals - Feb 27, 2024

$2.55M Octapharma Plasma data breach class action settlement - Class Action Lawsuits

Class Action Lawsuits - Nov 15, 2025

Octapharma Plasma opens its first New York donation center in Amherst - Niagara Frontier Publications

Niagara Frontier Publications - Sep 07, 2022

Octapharma issues recall of one lot of its immune globulin Octagam - Fierce Pharma

Fierce Pharma - Apr 28, 2016

Patients Net $2.55M Deal To End Plasma Co. Data Breach Case - Law360

Law360 - Nov 17, 2025

Pfizer recieves FDA approval for Panzyga to treat CIDP - Pfizer

Pfizer - Mar 19, 2022

Octapharma Uses IVIG as Potential Treatment for COVID-19 - BioSpace

BioSpace - Aug 06, 2020

Blood money: Octapharma facility, offering cash for plasma, pops up in Brockton - Enterprise News

Enterprise News - Aug 11, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment